LINC01555

Across TCGA pan-cancer cohorts, LINC01555 RNA is linked to patient survival in 17 of 34 cancer types, making it the most broadly survival-associated LINC01555 data layer.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where higher LINC01555 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated LINC01555 expression acts as an unfavorable survival marker, although some lineages such as READ and OV show a favorable association.

HNSC, READ, and DLBC are the cancer types where LINC01555 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
HNSC	OS	Tertile	All	0.663	0.792	<.001	117	view →
READ	OS	Median	II,III,IV	0.786	0.454	.001	81	view →
DLBC	OS	Tertile	II,III,IV	0.172	0.949	<.001	78	view →
OV	OS	Quartile	All	0.430	0.277	.001	64	view →
ACC	OS	Tertile	All	0.266	0.809	.001	36	view →
LIHC	OS	Tertile	All	0.545	0.719	<.001	35	view →
LGG	DFS	Tertile	All	0.324	0.485	<.001	32	view →
THCA	DFS	Tertile	All	0.946	0.870	.019	25	view →
STAD	OS	Quartile	III,IV	0.208	0.688	<.001	24	view →
COAD	DFS	Quartile	All	0.770	0.631	.009	22	view →
BLCA	DFS	Tertile	IV	0.494	0.171	.002	16	view →
ESCA	OS	Quartile	All	0.661	0.840	.029	8	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 17 lineages.

LINC01555–HNSC (OS)

Open the HNSC breakdown →